Coagulation Diagnostics – Blood Clotting Tests

What Is Coagulation Diagnostics?

Coagulation diagnostics is a branch of laboratory medicine focused on evaluating the blood clotting (coagulation) system. It includes a range of laboratory tests designed to determine whether a patient´s blood clots normally, clots too readily, or has a reduced ability to form clots. Coagulation diagnostics plays a critical role in both emergency medicine and routine clinical care.

Basics of Blood Coagulation

Blood coagulation is a complex, multi-step process that stops bleeding after a blood vessel is injured. There are two main pathways:

• Primary hemostasis: Platelets adhere to the site of injury and form an initial plug.
• Secondary hemostasis (coagulation cascade): A series of clotting factors are activated, ultimately producing a stable fibrin clot.

Disruptions in either of these steps can lead to excessive bleeding or, conversely, an increased tendency to form clots inside blood vessels (thrombosis).

Indications for Coagulation Diagnostics

Coagulation testing is ordered in the following situations:

• Before surgical procedures to assess bleeding risk
• For unexplained or recurrent bleeding (e.g., frequent nosebleeds, heavy menstrual bleeding)
• When thrombosis or pulmonary embolism is suspected
• To monitor anticoagulant therapy
• When an inherited or acquired bleeding disorder is suspected
• In liver disease, since the liver produces most clotting factors

Key Tests in Coagulation Diagnostics

Prothrombin Time (PT) and INR

The prothrombin time (PT) measures the activity of the extrinsic coagulation pathway and reflects the function of clotting factors I, II, V, VII, and X. The INR (International Normalized Ratio) is a standardized value derived from the PT, used primarily to monitor therapy with vitamin K antagonists (e.g., warfarin, phenprocoumon). A normal INR value is approximately 0.8 to 1.2.

aPTT

The activated partial thromboplastin time (aPTT) evaluates the intrinsic coagulation pathway and measures the activity of factors VIII, IX, XI, and XII, as well as the common pathway. It is expressed in seconds and is used to monitor heparin therapy. Normal values typically range from 25 to 38 seconds, depending on the laboratory.

Fibrinogen

Fibrinogen is a key protein in the coagulation cascade that is converted into fibrin at the end of the process. Low fibrinogen levels may indicate increased consumption (e.g., in disseminated intravascular coagulation) or reduced production (e.g., in severe liver disease).

Thrombin Time (TT)

The thrombin time measures how long it takes to convert fibrinogen into fibrin. It is prolonged in cases of fibrinogen deficiency, the presence of heparin in the blood, or certain fibrinogen functional disorders.

D-Dimers

D-dimers are degradation products of cross-linked fibrin, produced when blood clots are broken down. Elevated D-dimer levels may indicate an active thrombosis, pulmonary embolism, or disseminated intravascular coagulation (DIC). However, the test has low specificity, as D-dimers can also be elevated during inflammation, infection, or after surgery.

Platelet Count and Function

The platelet count is part of the complete blood count. In addition, platelet function can be assessed using specialized tests such as platelet aggregation testing (e.g., using the PFA-100 analyzer) or light transmission aggregometry (LTA).

Individual Clotting Factor Assays

When a specific clotting disorder is suspected, the activity of individual clotting factors can be measured (e.g., factor VIII in hemophilia A, factor IX in hemophilia B).

Thrombophilia Workup

A thrombophilia workup investigates inherited or acquired risk factors for excessive clotting (thrombophilia). Common tests include:

• Factor V Leiden mutation (cause of APC resistance)
• Prothrombin gene mutation (G20210A)
• Protein C and protein S deficiency
• Antithrombin deficiency
• Antiphospholipid syndrome (lupus anticoagulant, anticardiolipin antibodies)

Pre-Analytics and Sample Collection

Proper sample collection is essential for accurate coagulation testing. Blood is drawn into special citrate tubes (blue-top tubes), as sodium citrate inhibits clotting and preserves the sample for analysis. The tube must be filled exactly to the marked line, as an incorrect citrate-to-blood ratio can distort results. Samples should be transported and analyzed promptly.

Interpretation of Results

Coagulation results must always be interpreted in the clinical context. Isolated abnormalities in individual parameters can have various causes and must be correlated with the patient´s medical history and symptoms. Significant findings typically prompt further evaluation by a specialist in hematology or hemostaseology.

References

1. Pötzsch B, Madlener K (eds.): Haemostaseology. Springer Medizin Verlag, 2nd edition, 2010.
2. Levi M et al.: Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology, 145(1):24-33, 2009. Available at: https://pubmed.ncbi.nlm.nih.gov/19222477/
3. Kottke-Marchant K, Davis B (eds.): Laboratory Hematology Practice. Wiley-Blackwell, 2012.